Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Cancer Screening 50%
• Cell Proliferation 50%
• Follistatin 50%
• Liquid Chromatography-Mass Spectrometry 50%
• Lysine 50%
• Osteoclastogenesis 100%
• Pentraxin 50%
• Protein Family 50%
• Proteomics 100%
• Screening Test 50%
• Secretion (Process) 50%
• Secretome 100%
• Serpin 100%
• Tandem Mass Spectrometry 50%
• Transforming Growth Factor Beta 100%
• Western Blot 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 50%
• Bone Metastasis 50%
• Follistatin 16%
• Lysine 16%
• Malignant Neoplasm 33%
• Pentraxin 16%
• Prostate Cancer 100%
• Serine Proteinase Inhibitor 33%
• Transforming Growth Factor Beta 33%
• Western Blot 16%

Immunology and Microbiology

• Bone Metastasis Cell Line 50%
• Cancer Screening 50%
• Prostate Cell Line 50%
• Screening Test 50%
• Transforming Growth Factor Beta 100%